Surgical intervention versus conservative care in severe hypertensive pontine hemorrhage: a retrospective analysis of clinical outcomes - Report - MDSpire
Advertisement
Surgical intervention versus conservative care in severe hypertensive pontine hemorrhage: a retrospective analysis of clinical outcomes
Clinical Report: Comparative Outcomes of Surgical and Conservative Management in Severe Hypertensive Pontine Hemorrhage
Overview
Revise to clarify that surgical management is associated with lower mortality and unfavorable outcomes compared to pharmacological therapy, based on study findings.
Background
Hypertensive pontine hemorrhage is a critical condition with high mortality and disability rates, yet lacks standardized treatment guidelines. Understanding the comparative outcomes of surgical and conservative management is essential for optimizing patient care and improving prognostic assessments in this severe clinical scenario.
Data Highlights
Group
30-Day Mortality
90-Day Mortality
90-Day Unfavorable Outcomes (mRS ≥ 4)
Surgical
Significantly lower
Significantly lower
Significantly lower
Pharmacological
Higher
Higher
Higher
Key Findings
Surgical management resulted in significantly lower 30/90-day mortality compared to pharmacological treatment (P < 0.05).
90-day unfavorable functional outcomes were also significantly lower in the surgical group (P < 0.05).
No significant difference in 30-day unfavorable outcomes between groups (P = 0.087).
Craniotomy showed higher hematoma clearance but increased risk of intracranial infection.
Stereotactic drainage offered shorter ICU and hospital stays but had a higher risk of rebleeding.
Older age, lower GCS score, larger hematoma volume, and acute obstructive hydrocephalus were identified as adverse prognostic factors.
Clinical Implications
The findings suggest that surgical intervention may be preferable for patients with severe HPH, particularly in reducing mortality and improving functional outcomes. Clinicians should consider individual patient characteristics and hematoma features when deciding on treatment strategies.
Conclusion
Reiterate the need for caution in interpreting results and the necessity for further research.
Aviva Abosch, M.D., Ph.D., a neurosurgeon at Baptist Health Miami Neuroscience Institute, part of Baptist Health Brain and Spine Care, was installed as the Esernia Endowed Chair in Surgical Treatment of Adult Epilepsy and Movement Disorders.
Baptist Health Foundation announced that it has received a $2 million donation from Anthony and Joyce Esernia to establish a new endowed chair at Baptist Health Miami Neuroscience Institute.
